Publications
Specialty
Search
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/10/2024
“We found that regular use of acetaminophen at concentrations that are considered safe—equivalent to 500 mg/day—causes numerous signaling pathways inside the heart to be altered,” said Gabriela Rivera, the study’s first author. “These results prompt me to consider using acetaminophen at the lowest effective dose and for the shortest duration possible.”
Oncology, Lymphoma, Leukemia & Myeloma Network
04/10/2024
During the 2024 Great Debates & Updates in Hematological Malignancies Meeting, Aditi Shastri, MD, shares expert insight on recent updates in risk stratification and treatment regimens for patients with low to intermediate risk myelodysplastic syndromes.
EMSWorld
04/10/2024
Patients’ and providers’ religious views related to the administration of whole blood; Abdo Khoury on emergency medicine physician shortages in France; Corey Slovis on ECGs and resolved STEMIs; Amal Mattu on “shark fin STEMI”; and more.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/10/2024
“Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD, the study’s principal investigator. “Based on our study’s results, we can say that the drug worked and appeared to be safe. We tested two doses of olezarsen, and both reduced triglyceride levels equally well.”
EMSWorld
04/10/2024
With the threat of HIPAA breaches growing, find out how your organization can avoid cyberattacks and protect itself from a data breach.
Oncology
04/10/2024
What was the median progression-free survival for endometrial cancer treated with monotherapy after disease progression following initial treatment?
Wound Care
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Repost
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/10/2024
“In the next five years, new pumps will have a fully internalized power line and be wirelessly powered from outside the body, just like our iPhones,” said Mandeep R. Mehra, MD, of the Center for Advanced Heart Disease at Brigham Health. “We’ll implant these devices, and the patient will be able to forget about them.”
Lymphoma, Leukemia & Myeloma Network, Oncology
04/10/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Joseph Mikhael, MD, MEd, FRCPC, FACP, evaluates whether or not quadruplet therapy should be the new standard-of-care treatment for patients with multiple myeloma who are transplant-eligible versus transplant-ineligible, highlighting the results of the PERSEUS, IsKia, and MAIA trials.
Psych Congress NP Institute
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Pharmacy Learning Network
04/10/2024
In adults with nonalcoholic steatohepatitis (NASH), resmetirom was superior to placebo for the outcomes of NASH resolution and improvement in liver fibrosis by at least one stage, according to a study published in The New England Journal of Medicine.
EMSWorld
04/10/2024
North Texas is firmly in its severe weather season, which lasts from March to June. During this period various types of severe weather are possible, from hail and damaging winds to lighting and tornadoes.
Integrated Healthcare Executive
04/10/2024
Regard, an AI clinical platform, is expanding its partnership with Banner Health to introduce its diagnostic tool across all 33 Banner acute-care hospitals in 2024, following a successful pilot, according to a news release by PR Newswire.
The Dermatologist
04/10/2024
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
Pharmacy Learning Network
04/09/2024
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
EMSWorld
04/09/2024
Regardless, here’s how to tell if you might have eye damage from the solar eclipse and what to do about it.
Veterans Health Today
04/09/2024
The outpatient Chattanooga VA Clinic, Chattanooga, Tennessee, recently partnered with a local hospital breast center to provide mammography services to veterans in the community via a mobile mammogram bus, according to VA News report.
EMSWorld
04/09/2024
To manage excessive offload times keeping ambulances off the streets, the city-run Ottawa Paramedic Service will begin transporting non-critical patients to the hospital by taxi.
Oncology
04/09/2024
Results from the phase 3 CONTACT-01 trial demonstrated that atezolizumab plus cabozantinib did not improve OS or PFS compared to docetaxel among patients with metastatic NSCLC who experienced disease progression after prior treatment.
Annals of Long-Term Care
04/09/2024
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
